Centaura is a pioneering brand that consists of a young, global team of ambitious thinkers dedicated to making groundbreaking discoveries in aging research. They are revolutionizing the field of human gene editing and have developed a technology that introduces large DNA sequences into cells reliably, safely, and without causing an immune response. Their focus is on creating a gene editing technique that does not involve cutting the genome itself, which can be utilized widely.

With their expertise, Centaura aims to improve human health and increase lifespan. One of their notable advancements is the development of a Human Artificial Chromosome (HAC), which acts as a versatile multi-gene delivery platform for genetically engineering human cells. This platform enables easier diagnosis and treatment of various diseases and can express genes with multiple therapeutic or bio-production functions.

From biologics to therapeutic proteins and real-time responsive biosensors, the possibilities are vast. Although the technology to grow wings is still distant, Centaura's technology can already produce effective drugs and enhance human lives through gene editing. The brand is actively focused on overcoming the existing lifespan barrier and achieving a genuine breakthrough in extending human life.

With their passionate team and dedication to scientific advancements, Centaura is leading the way in the field of gene editing and revolutionizing the future of healthcare. For inquiries, please contact Centaura at their Zurich office